Header Logo

Connection

DAVID FOGELMAN to Neuroectodermal Tumors, Primitive

Back to Details
This is a "connection" page, showing publications DAVID FOGELMAN has written about Neuroectodermal Tumors, Primitive.
DAVID FOGELMAN
Connection Strength
0.050
Neuroectodermal Tumors, Primitive
  1. Assessment of Clinical Response Following Atezolizumab and Bevacizumab Treatment in Patients With Neuroendocrine Tumors: A Nonrandomized Clinical Trial. JAMA Oncol. 2022 06 01; 8(6):904-909.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.